Radiation with additional antiandrogen therapy in recurrent prostate cancer

被引：0
作者：
Roth, Stephan [1 ]
机构：
[1] Univ Klinikum Dusseldorf, Klin & Poliklin Strahlentherapie & Radioonkol, Moorenstr 5, D-40225 Dusseldorf, Germany
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2017年 / 193卷 / 08期
关键词：
RADICAL PROSTATECTOMY; ANDROGEN SUPPRESSION; SALVAGE RADIOTHERAPY; PHASE-3; TRIAL; ADJUVANT; OUTCOMES; SURVIVAL; ANTIGEN;
D O I：
10.1007/s00066-017-1171-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：679 / 681
页数：3
相关论文
共 21 条
  • [11] Casodex (bicalutamide) 150-MG monotherapy compared with castration in patients with previously untreated nonmetastatic prostate cancer: Results from two multicenter randomized trials at a median follow-up of 4 years
    Iversen, P
    Tyrrell, CJ
    Kaisary, AV
    Anderson, JB
    Baert, L
    Tammela, T
    Chamberlain, M
    Carroll, K
    Gotting-Smith, K
    Blackledge, GRP
    [J]. UROLOGY, 1998, 51 (03) : 389 - 396
  • [12] Addition of Radiotherapy to Long-Term Androgen Deprivation in Locally Advanced Prostate Cancer: An Open Randomised Phase 3 Trial
    Mottet, Nicolas
    Peneau, Michel
    Mazeron, Jean-Jacques
    Molinie, Vincent
    Richaud, Pierre
    [J]. EUROPEAN UROLOGY, 2012, 62 (02) : 213 - 219
  • [13] A MATCHED CONTROL ANALYSIS OF ADJUVANT AND SALVAGE HIGH-DOSE POSTOPERATIVE INTENSITY-MODULATED RADIOTHERAPY FOR PROSTATE CANCER
    Ost, Piet
    De Troyer, Bart
    Fonteyne, Valerie
    Oosterlinck, Willem
    De Meerleer, Gert
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 80 (05): : 1316 - 1322
  • [14] Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: Report of Radiation Therapy Oncology Group Protocol 85-31
    Pilepich, MV
    Caplan, R
    Byhardt, RW
    Lawton, CA
    Gallagher, MJ
    Mesic, JB
    Hanks, GE
    Coughlin, CT
    Porter, A
    Shipley, WU
    Grignon, D
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (03) : 1013 - 1021
  • [15] No Evidence for Improved Outcome with Salvage Radiotherapy for asymptomatic biochemical Prostate Cancer Recurrence after Prostatectomy by additive Androgen Suppression
    Schuler, Helena Garcia
    Guckenberger, Matthias
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2017, 193 (01) : 86 - 88
  • [16] Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer
    Shipley, W. U.
    Seiferheld, W.
    Lukka, H. R.
    Major, P. P.
    Heney, N. M.
    Grignon, D. J.
    Sartor, O.
    Patel, M. P.
    Bahary, J. -P.
    Zietman, A. L.
    Pisansky, T. M.
    Zeitzer, K. L.
    Lawton, C. A. F.
    Feng, F. Y.
    Lovett, R. D.
    Balogh, A. G.
    Souhami, L.
    Rosenthal, S. A.
    Kerlin, K. J.
    Dignam, J. J.
    Pugh, S. L.
    Sandler, H. M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (05) : 417 - 428
  • [17] Soto DE, 2012, INT J RADIAT ONCOL, V82, P112
  • [18] Improved Metastasis-Free and Survival Outcomes With Early Salvage Radiotherapy in Men With Detectable Prostate-Specific Antigen After Prostatectomy for Prostate Cancer
    Stish, Bradley J.
    Pisansky, Thomas M.
    Harmsen, William S.
    Davis, Brian J.
    Tzou, Katherine S.
    Choo, Richard
    Buskirk, Steven J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (32) : 3864 - +
  • [19] Adjuvant radiation therapy is associated with better oncological outcome compared with salvage radiation therapy in patients with pN1 prostate cancer treated with radical prostatectomy
    Tilki, Derya
    Preisser, Felix
    Tennstedt, Pierre
    Tober, Patrick
    Mandel, Philipp
    Schlomm, Thorsten
    Steuber, Thomas
    Huland, Hartwig
    Schwarz, Rudolf
    Petersen, Cordula
    Graefen, Markus
    Ahyai, Sascha
    [J]. BJU INTERNATIONAL, 2017, 119 (05) : 717 - 723
  • [20] ACHIEVING AN UNDETECTABLE PSA AFTER RADIOTHERAPY FOR BIOCHEMICAL PROGRESSION AFTER RADICAL PROSTATECTOMY IS AN INDEPENDENT PREDICTOR OF BIOCHEMICAL OUTCOME-RESULTS OF A RETROSPECTIVE STUDY
    Wiegel, Thomas
    Lohm, Gunnar
    Bottke, Dirk
    Hoecht, Stefan
    Miller, Kurt
    Siegmann, Alessandra
    Schostak, Martin
    Neumann, Konrad
    Hinkelbein, Wolfgang
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 73 (04): : 1009 - 1016
123